Skip to content

Strategies to reduce non communicable diseases in South India

Strategies for non-communicable disease prevention in select populations residing in different regions of India

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052588
Enrollment
350
Registered
2023-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N17-N19- Acute kidney failure and chronic kidney disease Health Condition 2: I60-I69- Cerebrovascular diseases Health Condition 3: J40-J47- Chronic lower respiratory diseases Health Condition 4: I10- Essential (primary) hypertension Health Condition 5: I20-I25- Ischemic heart diseases Health Condition 6: C00-D49- Neoplasms Health Condition 7: E660- Obesity due to excess calories Health Condition 8: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Educational intervention: Education to improve lifestyle habits, medication adherence and appropriate referral and follow-up. Control Intervention1: Not Applicable: Not Applicable as it

Sponsors

SOCHARA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Known H/O or Diagnosed at screening with hypertension, diabetes, COPD, depression, anxiety, or common cancers as oral, breast and cervical cancer on or off treatment 2.Any of the lifestyle related NCD risk factors such as tobacco usage, obesity, Physical inactivity, dyslipidemias, and alcohol abuse

Exclusion criteria

Exclusion criteria: 1.Severe cognitive impairment without a primary caregiver 2.Unable to follow-up for a period of 6 months. 3. Pregnant women

Design outcomes

Primary

MeasureTime frame
1.Change in NCD Risk factor levels before and after interventionTimepoint: Baseline and 6 months

Secondary

MeasureTime frame
1.Change in the biochemical parameters - fasting blood sugar and total cholesterol. 2.Clinical NCD outcomes – NCD related hospitalisations or death (All-cause mortality) 3.Implementation metrics 4.Feasibility outcomes Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Aakanksha Singh

St Johns Research Institute

deepa.sn@sjri.res.in08049467081

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026